LabCorp and Cedars-Sinai-backed Emulate will use the cash to further develop its organ-on-a-chip technology and has now raised nearly $225m in total.
Emulate, a US-based biotechnology developer backed by clinical laboratory network operator LabCorp and hospital Cedars-Sinai Medical Center, raised $82m in a series E round yesterday.
Venture capital firm Northpond Ventures led the round, which was filled out by Perceptive Advisors, bringing the company’s total funding to almost $225m.
Emulate is developing in vitro on-a-chip models of human organs that replicate their function, in order to aid research in human response to drugs.
In addition to potentially accelerating the drug discovery…
Fernando Moncada Rivera
Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
